| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | rofecoxib | FAERS: 2 | OFFSIDES US FAERS | |
| 2 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | FAERS: 1 | US FAERS | |
| 3 | Atorvastatin | FAERS: 1 | US FAERS | |
| 4 | Celecoxib | FAERS: 1 | US FAERS | |
| 5 | Linezolid | FAERS: 1 | US FAERS | |
| 6 | Rivastigmine | FAERS: 1 | US FAERS | |
| 7 | Teriparatide | FAERS: 1 | US FAERS | |
| 8 | Alendronate | OFFSIDES | ||
| 9 | Bisacodyl | OFFSIDES | ||
| 10 | Bortezomib | OFFSIDES | ||
| 11 | Bromocriptine | OFFSIDES | ||
| 12 | Dacarbazine | OFFSIDES | ||
| 13 | Deferasirox | OFFSIDES | ||
| 14 | Leflunomide | OFFSIDES | ||
| 15 | Letrozole | OFFSIDES | ||
| 16 | Pamidronate | OFFSIDES | ||
| 17 | Prednisone | OFFSIDES | ||
| 18 | Ribavirin | OFFSIDES | ||
| 19 | Zoledronic Acid | OFFSIDES | ||
| 20 | mannosamine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.